C

Cerevance

56 employees

Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Life Science

Date founded

2016

Funding rounds raised

Total raised

$65M

from 20 investors over 20 rounds

C

Cerevance raised $51M on February 13, 2023

Investors: Dolby Family Ventures, The Dementia Discovery Fund, GV, Foresite Capital, Lightstone Ventures, UPMC Enterprises and Takeda UK Limited

C

Cerevance raised $65M on April 14, 2020

Investors: Foresite Capital, GV, Takeda UK Limited, Lightstone Ventures, UPMC Enterprises, The Dementia Discovery Fund, Dolby Family Ventures and Casdin Capital, LLC

C

Cerevance raised undisclosed on February 21, 2018

Investors: The Dementia Discovery Fund

C

Cerevance raised $5M on May 3, 2017

Investors: Lightstone Ventures, SV Life Sciences and The Dementia Discovery Fund

C

Cerevance raised $22M on December 2, 2016

Investors: Lightstone Ventures

FAQ